Together with 7 other commercially available oral rinses based upon different active components the viral reduction was measured. In summary, Cavex Oral Pre Rinse showed sufficient evidence that the Coronavirus can be efficiently inactivated within a short exposure time of 30 seconds. This shows the effectiveness of Cavex Oral Pre-Rinse against the coronavirus.
Abstract: Virucidal efficacy of different oral rinses against SARS-CoV-2
The ongoing SARS-CoV-2 pandemic creates a significant threat to global health. Recent studies suggested the significance of throat and salivary glands as major sites of virus replication and transmission during early COVID-19 outbreak thus advocating application of oral antiseptics. However, the antiviral efficacy of oral rinsing solutions against SARS-CoV-2 had not been examined yet.
Here, we evaluated the virucidal activity of different available oral rinses against SARS-CoV-2 under conditions mimicking nasopharyngeal secretions. Several formulations with significant SARS-CoV-2 inactivating properties in-vitro support the idea that oral rinsing might reduce the viral load of saliva and could thus lower the transmission of SARS-CoV-2.
The full abstract is available here.
More information is available on the product page.
If you want to know more about the effectiveness of Cavex Oral Pre-Rinse against the coronavirus, contact us by clicking here.